Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Tivic Health Systems Inc TIVC

Tivic Health Systems, Inc. operates as a late-stage immunotherapeutics company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company’s pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications. In addition, it offers CDMO services. The company was incorporated in 2016 and is based in San Antonio, Texas.


NDAQ:TIVC - Post by User

User Avatar Image
(1441)
•••
  • IseneschalX
Post by Iseneschalon Apr 03, 2025 8:17am
45 Views
Post# 36521843

TIVC....now that I don't have a position...I bet it goes way

TIVC....now that I don't have a position...I bet it goes wayHigher ; )

Currently trading at $5.70 on 15 million shares in PM trading


<< Previous
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities